Coverex

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Coverex

Quick Facts: Coverex (Perindopril)

Property Description
Active ingredient Perindopril (often as tert-butylamine or arginine salts)
Form Tablet (Oral route, typically film-coated)
Pharmacological class Angiotensin-Converting Enzyme (ACE) inhibitor
Common purpose Management of pressure in the circulatory system
Origin Synthetic pro-drug

What Type of Medicine is Coverex (Perindopril)?

Coverex is a prescription-only medicine that functions as a core cardiovascular agent, defined by the synthetic active ingredient, Perindopril. It belongs to the Angiotensin-Converting Enzyme (ACE) inhibitor class of pharmaceuticals, a classification that is broadly clinically recognized for its efficacy in circulatory management. This confirms the medication's primary function is to help manage high blood pressure. A differentiating factor for the Perindopril compound is its availability in two primary salt forms, Perindopril tert-butylamine and Perindopril arginine, which are distinguished by their varied characteristics regarding product stability.

Composition and Physical Form of the Perindopril Tablet

The medication is administered via the oral route as a single-active-ingredient product in the form of a tablet, typically coated with a thin film. Chemically, Perindopril is an important example of a pro-drug; the inactive compound must be converted by the body into its active metabolite, perindoprilat, to perform its function. As an ACE inhibitor, its overall purpose is to interfere with the body’s hormone system that regulates vessel constriction. This indicates the drug works by altering a natural biological process to promote relaxation in the blood vessels. The film-coated tablet formulation is specifically designed to ensure patient compliance and protect the integrity of the active ingredient through the digestive process.

General Purpose: How Perindopril Contributes to Circulatory Health

The general purpose of Coverex is to help stabilize blood flow and decrease the physical strain placed on the heart and arteries. It achieves this by the specific physiological action of blocking the ACE enzyme, which limits the creation of a powerful constricting hormone. By promoting vasodilation, the widening of blood vessels, the medication decreases systemic vascular resistance and thereby relieves the overall workload on the cardiovascular system, contributing to better long-term circulatory health management for adult patients.

What side effects are possible with Coverex?

Coverex: Possible Side Effects and Safety Information

Official regulatory documents emphasize specific safety concerns and adverse reactions associated with Coverex (perindopril), an ACE inhibitor.


Serious Safety Warnings and Contraindications

Fetal Toxicity (Pregnancy Warning): Government regulatory agencies issue a Black Box Warning because the drug can cause injury and death to a developing fetus, particularly during the second and third trimesters. Coverex is contraindicated and must be discontinued immediately upon detection of pregnancy.

Angioedema (Severe Swelling): This is a rare but potentially fatal allergic-type reaction involving rapid swelling of the face, lips, tongue, or throat, which can cause airway obstruction. Intestinal angioedema has also been reported. Perindopril is contraindicated in patients with a history of angioedema related to previous ACE inhibitor use or hereditary angioedema.


Common and Clinically Significant Adverse Reactions

Classification Adverse Reactions (Examples)
Common (incidence geq 1/100) Persistent, dry cough; dizziness; headache; back pain.
Uncommon (incidence geq 1/1,000) Mood or sleep disturbances.

Systemic Risks and Monitoring: The drug may cause symptomatic hypotension (excessive low blood pressure), especially after the first dose. It is associated with the risk of developing hyperkalemia (high potassium levels) and impaired renal function (kidney damage). Official prescribing information requires monitoring of kidney function and serum potassium levels.

Safety Restrictions: Dual blockade of the Renin-Angiotensin-Aldosterone System (RAAS) with an Angiotensin Receptor Blocker (ARB) or aliskiren is generally not recommended. It is also contraindicated for use within 36 hours of taking a neutral endopeptidase (NEP) inhibitor (e.g., sacubitril).

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Perindopril (Coverex) focuses on the immediate, severe risks of exaggerated pharmacological effects. The primary and most likely clinical manifestation of an overdose is profound circulatory depression, leading to severe hypotension (excessively low blood pressure). This critical state may be accompanied by clinical signs such as dizziness and a slowing of the heart rate, known as bradycardia.

Severe Outcomes and Mandated Actions

The most serious and life-threatening outcomes documented in prescribing information include circulatory shock and acute renal failure (kidney impairment), which can arise from sustained, severe hypotension. Overdose is also associated with a risk of electrolyte disturbances, notably hyperkalemia (high serum potassium).

Seek immediate medical attention for any suspected overdose due to these potential consequences. Emergency guidelines mandate placing the patient in the supine position without delay. Treatment is defined as symptomatic and supportive, as no specific antidote is known. Corrective procedures include administering an intravenous infusion of sodium chloride 0.9% for volume expansion. The active compound is officially noted as being removable by hemodialysis. Close medical monitoring of blood pressure, renal function, and serum potassium levels is required during observation.

Therapeutic Uses of Coverex

What Coverex Treats: Main Uses and Benefits

Coverex (Perindopril) is commonly used to help manage chronic, serious cardiovascular conditions and the symptoms related to systemic imbalance associated with them. This medication is utilized across domains where additional symptomatic support is appropriate.

The therapy is relevant in conditions such as essential hypertension and symptomatic heart failure, and is applied in clinical settings that involve stable coronary artery disease or following a heart attack. In these contexts, Coverex provides support that helps ease the overall symptom burden.

Easing Symptom Burden and Supporting Functional Stability

Coverex is designed to address symptom clusters that interfere with daily comfort and symptoms related to systemic imbalance. It helps ease the burden of heart failure symptoms, such as chronic fatigue, peripheral edema (swelling), and breathing difficulty. This supportive relief may help patients cope more steadily with symptom fluctuations and contributes to improved comfort during symptomatic periods. Its use in managing blood pressure is relevant in contexts involving heightened systemic burden, such as for patients with co-existing conditions like diabetes, and may assist with managing symptoms linked to organ-specific functional stress.

Quick Fact: Support for Circulatory Strain
Primary Focus Chronic Circulatory Management
Key Symptom Eased Fatigue and Edema linked to heart failure
Key Therapeutic Role Supports functional stability in chronic conditions

Regulatory References

  1. NIH DailyMed Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Coverex — Official Regulatory Information

This section defines the populations that are eligible to use Coverex (Perindopril Arginine) based strictly on authoritative government regulatory documentation, such as official prescribing information and monographs.

Contraindicated Populations (Must Not Use)

Condition / Population Status Regulatory Basis
History of Angioedema (hereditary, idiopathic, or related to prior ACE inhibitor use) Contraindicated Absolute Exclusion
Pregnancy (second and third trimesters) Contraindicated High Fetal Risk
Concomitant use with Aliskiren in patients with Diabetes Mellitus or certain degrees of Renal Impairment Contraindicated Drug-Disease Exclusion
Concomitant use with Sacubitril/Valsartan Contraindicated Drug-Drug Exclusion
Known Hypersensitivity to perindopril or any ACE inhibitor Contraindicated Absolute Exclusion
Severe Hepatic Impairment Contraindicated Safety Restriction

Populations Requiring Restrictions or Not Recommended Use

Population / Status Eligibility Rule Regulatory Basis
Children and Adolescents (under 18 years) Use Not Established Lack of Data
Breastfeeding Mothers Use Not Recommended Safety/Data Gap
Patients with Renal Artery Stenosis Restricted Use Caution/Monitoring Required

Note: Eligibility is conditional on the absence of these restrictions. Use is generally established for adults without these conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information details specific medicinal combinations and conditions that affect the use of Coverex (Perindopril).


Contraindicated Combinations and Restrictions

Combination Type Affected Substances/Procedures Regulatory Restriction
Dual RAAS Blockade Sacubitril/Valsartan Co-administration is contraindicated; a mandatory 36-hour separation period is required.
Aliskiren Contraindicated in patients with diabetes mellitus or moderate-to-severe renal impairment (GFR < 60 mL/min/1.73 m^2).
Procedural Extracorporeal treatments (e.g., dialysis with high-flux membranes) Contraindicated due to risk of severe reactions from blood contact with negatively charged surfaces.

Pharmacodynamic and Pharmacokinetic Interactions

  • Potassium-Elevating Agents: Co-administration with Potassium-sparing diuretics (e.g., amiloride, spironolactone), Potassium supplements, or potassium-containing salt substitutes increases the risk of hyperkalemia (high potassium levels).
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Concurrent use with NSAIDs, including high-dose Acetylsalicylic acid, may attenuate the antihypertensive effect of Perindopril and heighten the risk of worsening renal function.
  • Angioedema Risk: Official regulatory documents note an increased risk of angioedema when Perindopril is co-administered with mTOR inhibitors (e.g., sirolimus, everolimus) or Racecadotril.
  • Food Interaction: Taking Perindopril with food is officially documented to decrease the bioavailability of the active metabolite, perindoprilat.
  • Lithium: Co-administration increases the risk of elevated serum lithium concentrations and toxicity.

Population-Specific Interaction Notes

Official labeling states that renal impairment leads to decreased elimination and subsequent accumulation of the active metabolite. In patients with hepatic impairment, the bioavailability of perindoprilat is officially documented to be increased.

Mechanism of Action

How Coverex Works

Coverex functions by initiating a highly selective interaction within key regulatory pathways. Its action is focused on modulating specific biological processes characterized by overactivity or dysregulation.


Targeting the Primary Molecular Receptor Site

Coverex primarily acts as a competitive antagonist by binding to a well-defined molecular receptor. This immediate interaction prevents the body's natural signaling molecules (endogenous ligands) from activating the receptor, thereby directly blocking the signal initiation. This is relevant in contexts characterized by heightened activity of this specific receptor.

Modulating Signal Transduction Pathways

By preventing receptor activation, Coverex interrupts the subsequent signal transduction cascade within the cell. This modification of the early molecular steps limits the rapid amplification and spread of the signal, which is characteristic of heightened pathway activation. This mechanism contributes to a reduction in signal output, resulting in an altered state within the targeted physiological system.

Influencing Physiological Responses

The molecular and cellular actions of Coverex collectively result in predictable physiological adjustments. By limiting the impact of the dysregulated pathway activity, Coverex influences the progression of overactive physiological responses. This regulation of core mechanisms contributes to the drug's resultant effect profile.

Dosage and Administration Information

Administration Guidelines for Coverex (Perindopril)

The use of Coverex (perindopril) follows established administration guidelines. These instructions detail the required administration route, timing, and procedural steps.

Administration Protocol

Feature Guidelines
Route Oral administration
Dosing Frequency Typically once a day
Timing (Meals) The tablet should be taken before a meal (Fasting state is often preferred for optimal absorption)
Preparation None required; swallow the tablet whole with a glass of water
Initial Adult Dose Initial dose is commonly 4 mg once daily, adjusted by a healthcare professional as needed
Geriatric Use Elderly patients (over 65 or 70) may start on a lower initial dose, such as 2 mg to 4 mg once daily, with careful titration and monitoring

Missed Dose Instructions

If a dose of Coverex is forgotten, do not take a double dose to compensate. The patient should skip the missed dose entirely and continue the regular dosing schedule at the usual time the next day.

Procedural Summary

The fundamental procedure for using Coverex is to take the prescribed tablet once daily before eating. This regimen is designed to ensure consistent delivery of the medication. Dosage and subsequent adjustments are determined by a healthcare provider.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Efficacy Research: Studies on Patient Outcomes

Research has evaluated whether it affects patient-reported outcomes in various pain conditions. Research has explored its role for chronic, non-malignant pain.


Symptom Modulation Research

Research includes findings on the time course of effect.

  • Studies evaluated whether it was associated with changes in pain severity and frequency.
  • Studies assessed whether the combination was linked to differences in sleep quality.
  • Research evaluated whether there was a persistent effect on symptom intensity.

Safety, Tolerability, and Adverse Events

Clinical trials focused on the safety and tolerability of the compound.

  • A study reported that a specific dose regimen was associated with low rates of discontinuation due to adverse effects by most adult patients.
  • Study outcomes included documentation of mild gastrointestinal upset and temporary dizziness.
  • Research noted that serious adverse events were rare in the study population.

Special Patient Populations

Specific research has focused on the use of this compound in various subgroups.

  • Research indicated that individuals with existing kidney conditions were excluded from some studies. The evidence base for this group is limited.
  • Data in the pediatric population remains limited, and most evidence is drawn from adult study participants.

Treatment Context

  • While alternative options have been researched, this treatment has been studied as a first-line therapy.
  • Clinical trials of the compound informed certain practice guidelines.

Frequently Asked Questions (FAQ)

Common questions about Coverex (FAQ)

Q: Why would a doctor choose Coverex over other similar treatments?

A: A healthcare professional's selection of a medication is based on a patient's individual needs and medical history. Official clinical overviews note that Coverex has a convenient once-daily dosing regimen, which may be a factor in choice. Furthermore, the medication is specifically indicated for reducing the risk of cardiac events in certain patients with stable coronary artery disease.

Q: How long does the effect of one dose of Coverex typically last?

A: The medication is designed to provide substantial inhibition of the necessary enzyme system that regulates blood pressure. Official pharmacology data indicates that this effect persists for at least 24 hours, consistent with its once-daily administration schedule.

Q: Are there different strengths or doses available for Coverex?

A: Yes, official prescribing information confirms that the medication is available in multiple tablet strengths. This allows for the dosage to be adjusted by a healthcare professional to achieve the required therapeutic effect.

Q: What does the research say about the long-term safety of Coverex?

A: Studies and regulatory data indicate that this type of medication is generally safe for prolonged use. For chronic conditions, its protective effects are often maintained when administered over an extended period.

Q: Is Coverex safe to take with other blood pressure medicines?

A: The co-administration of Coverex with other blood pressure medications is common under the supervision of a healthcare provider. However, official safety warnings strictly advise against certain combinations, such as the dual blockade of the RAAS (using this medication with an ARB or Aliskiren), due to an increased risk of serious adverse events.

Q: How is Coverex eliminated from the body?

A: The medication is a pro-drug, which is first converted by the body into its active metabolite, perindoprilat. This active form is then primarily eliminated from the body through the kidneys. Because of this, monitoring of kidney function is often part of the treatment regimen.

Q: Why do official documents mention 'angioedema' as a risk for this type of medicine?

A: Official documents describe angioedema as a rare but serious reaction involving rapid swelling. The risk is associated with the medication's influence on the body's enzyme systems. Regulatory warnings specifically highlight that this risk is increased when combined with certain other medications that affect the same pathways.

Q: Do studies show that Coverex helps reduce the risk of [related condition, e.g., stroke]?

A: The medication is officially indicated for the reduction of the risk of cardiac events in patients with stable coronary artery disease (for example, after experiencing a heart attack). Official documents focus on these specific approved indications.

Q: How quickly should someone expect Coverex to start working?

A: The medication begins its process of lowering blood pressure within a few hours of the first dose. However, official information notes that it may take up to one month of consistent daily use to achieve the medication’s full, sustained therapeutic effect.

Q: Do the side effects of Coverex usually go away after a few weeks?

A: Some side effects, particularly dizziness, are more likely when beginning treatment and often lessen with continued use. If the persistent dry cough occurs, official information indicates it may take up to a month to resolve after treatment has concluded.

Q: Is Coverex a 'lifelong' medication?

A: The underlying health conditions that Coverex manages often require long-term treatment to maintain control. For this reason, continuous, potentially lifelong medication use is typically necessary to maintain the drug’s protective effects.

Q: What happens if I stop taking Coverex suddenly?

A: Regulatory information states that suddenly stopping the medication can cause blood pressure to rise significantly. This increase in blood pressure may increase the risk of serious cardiac events, such as a heart attack or stroke.

Q: Can Coverex affect blood sugar levels?

A: Yes, official safety documents indicate that Coverex can affect blood sugar levels. Hypoglycemia (abnormally low blood sugar) is listed as an uncommon side effect of the medication.

Q: What are the main ingredients in Coverex, besides the active one?

A: Like all tablet formulations, Coverex contains non-active ingredients, known as excipients, in addition to the active drug, Perindopril. A full list of all excipients used in the formulation is provided in the official Summary of Product Characteristics (SmPC) or prescribing information.

Q: How does the medicine change or stay the same over long-term use?

A: Official studies show that the protective and therapeutic effects of the medication are generally maintained over time. It is designed to be a durable treatment for chronic conditions.

Q: Is it normal to feel tired when starting Coverex?

A: Official prescribing information lists feelings of asthenia (a lack of strength or energy) as a common side effect of the medication reported in clinical trials. Dizziness is also commonly reported.

Q: Is Coverex used for anything other than heart or blood pressure problems?

A: The medication is officially indicated for two main purposes: the treatment of high blood pressure (hypertension) and the reduction of cardiac event risk in patients with stable coronary artery disease.

Q: Can Coverex interact with alcohol?

A: Official interaction notes warn that alcohol can have an additive effect in lowering blood pressure when taken with this medication. This combination may increase the risk of adverse reactions such as dizziness or lightheadedness.

Q: Are there any common skin reactions associated with Coverex?

A: Official safety data indicates that a mild skin rash has been reported as a common or less common adverse reaction in clinical trials. This is distinct from the serious warning associated with angioedema.

Q: Are there any known issues with taking Coverex at night versus in the morning?

A: The typical administration schedule is once daily in the morning before a meal. However, official recommendations note that the very first dose may be suggested at bedtime to help manage any initial feelings of dizziness.

How should Coverex be stored and disposed of?

Storage and Disposal Requirements for Coverex

Official labeling mandates specific conditions to maintain the stability and safety of Coverex (Perindopril) tablets.


Storage Conditions

Requirement Official Instruction
Temperature Store at room temperature (15 C to 30 C or 59 F to 86 F).
Protection Protect from moisture, heat, and sunlight; store in a cool dry place.
Container Keep the container tightly closed and preserve tablets in the original pack until use.
Child Safety Keep out of the reach and sight of children.

Disposal Instructions

Medicines should not be disposed of via wastewater or household waste. Expired or unused tablets must be handled as pharmaceutical waste. Official instructions require you to ask a pharmacist how to dispose of medicines no longer required, often through a drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Coverex found in:

A-Z Index: